Trial Profile
Phase I Study of Auranofin and Sirolimus in Adult Patients With Non-Small Cell Lung Cancer
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I
Latest Information Update: 24 Jun 2014
Price :
$35
*
At a glance
- Drugs Auranofin (Primary) ; Sirolimus (Primary)
- Indications Non-small cell lung cancer; Solid tumours
- Focus Adverse reactions; Therapeutic Use
- 24 Jun 2014 New trial record